RPID

RPID

Rapid Micro Biosystems Inc

Rapid Micro Biosystems provides products for detecting microbial contamination in pharmaceuticals, biologics, medical devices, and personal care products. Its Growth Direct platform automates microbial quality control testing, enhancing workflow efficiency for manufacturers.

⚕️ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago $92today

Score Overview

1 Year
Score
Net Growth-8.65%
Net TrendShrank
Net Income Consistency
Rev Growth4.73%
Rev TrendGrew
Revenue Consistency
5 Years
Score5.7
Net Growth30.36%
Net Trend60%
Net Income Consistency
Rev Growth51.41%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth30.36%
Net Trend60%
Net Income Consistency
Rev Growth51.41%
Rev Trend80%
Revenue Consistency

See the full market ranking →

Rapid Micro Biosystems Inc fundamental performance

Between 2021 and 2025, revenue grew from $ 23M to $ 33M and net income went from -$ 73M to -$ 47M. Revenue increased in 80% of the years measured; net income in 60%.

Rapid Micro Biosystems Inc currently holds a 5-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.69
1 Year2025-08-12
$ 2.68-36.94%
5 Years2021-08-12
$ 18.45-90.84%
All Time2021-07-15
$ 21.40-92.10%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 35M-$ 51M$ 19M
2025$ 33M-$ 47M$ 38M
2024$ 28M-$ 46M$ 50M
2023$ 22M-$ 52M$ 92M
2022$ 17M-$ 60M$ 108M
IPO2021$ 23M-$ 73M$ 193M

Explore beyond RPID

You're looking at Rapid Micro Biosystems Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies